Record NNP B-NP O
date NN I-NP O
: : O O
2093-03-07 CD O B-DATE
MARTHA NNP B-NP B-HOSPITAL
JEFFERSON NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
Stephen NNP B-NP B-DOCTOR
A.N. NNP I-NP I-DOCTOR
Xayachack NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
593 CD B-NP B-STREET
Will MD O I-STREET
St NNP B-NP I-STREET
Vicente NNP I-NP I-PATIENT
, , O I-PATIENT
Kadeem NNP B-NP I-PATIENT
Sandpoint NNP B-NP B-CITY
, , O O
MI NNP B-NP B-STATE
58543 CD I-NP B-ZIP
CK759182 . O B-MEDICALRECORD
( -LRB- B-NP I-PHONE
033 CD I-NP I-PHONE
) -RRB- I-NP I-PHONE
250-1408 CD I-NP I-PHONE
3-6-93 CD O B-DATE
HPI NNP B-NP O
: : O O
Kadeem NNP B-NP B-PATIENT
Vicente NNP I-NP I-PATIENT
comes VBZ B-VP O
in IN B-PP O
today NN B-NP O
for IN B-PP O
follow VB B-VP O
up RP B-PRT O
office NN B-NP O
visit NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
is VBZ B-VP O
seen VBN I-VP O
primarily RB B-ADVP O
for IN B-PP O
follow VB B-NP O
up RP B-VP O
regarding VBG I-VP O
his PRP$ B-NP O
history NN I-NP O
of IN B-PP O
hypertension NN B-NP O
, , O O
coronary JJ B-NP O
artery NN I-NP O
disease NN I-NP O
( -LRB- O O
the DT B-NP O
patient NN I-NP O
is VBZ B-VP O
status NN B-NP O
post NN I-NP O
inferior JJ I-NP O
wall NN I-NP O
MI NNP I-NP O
) -RRB- I-NP O
, , O O
benign JJ B-NP O
prostatic JJ I-NP O
hypertrophy NN I-NP O
and CC B-PP O
to TO B-PP O
a DT B-NP O
much RB I-NP O
lesser JJR I-NP O
extent NN I-NP O
osteoarthritis NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
is VBZ B-VP O
also RB I-VP O
followed VBN I-VP O
GERD-like JJ B-NP O
symptoms NNS I-NP O
. . B-VP O
With IN B-PP O
regard NN B-NP O
to TO B-PP O
the DT B-NP O
latter NN B-NP O
, , O O
the DT B-NP O
patient JJ I-NP O
notes NNS I-NP O
that IN B-PP O
since IN B-SBAR O
he PRP B-NP O
has VBZ B-VP O
been VBN I-VP O
off IN B-PP O
the DT B-NP O
Zantac NNP I-NP O
, , O O
he PRP B-NP O
initially RB B-ADVP O
saw VBD B-VP O
no DT B-NP O
change NN I-NP O
in IN B-PP O
his PRP$ B-NP O
ability NN I-NP O
to TO B-VP O
handle VB I-VP O
foods NNS B-NP O
; : O O
however RB B-ADVP O
, , O O
he PRP B-NP O
now RB B-LST O
notes NNS B-NP O
that IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
starting VBG I-VP O
to TO I-VP O
get VB I-VP O
some DT B-NP O
reflux NN I-NP O
and CC O O
feels VBZ B-VP O
slightly RB O O
uncomfortable JJ B-NP O
with IN B-PP O
this DT B-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
chest NN B-NP O
pain NN I-NP O
per IN B-PP O
se NN B-NP O
and CC O O
any DT B-NP O
symptoms NNS I-NP O
pertinent JJ B-ADVP O
to TO B-PP O
cardiovascular JJ B-NP O
disease NN I-NP O
, , O O
such JJ B-PP O
as IN I-PP O
chest NN B-NP O
heaviness NN I-NP O
, , O O
shortness NN B-NP O
of IN B-PP O
breath NN B-NP O
, , I-NP O
diaphoresis NN I-NP O
, , I-NP O
nausea NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
knows VBZ B-VP O
the DT B-NP O
foods NNS I-NP O
that IN B-PP O
give VB O O
him PRP B-NP O
this DT B-NP O
type NN I-NP O
of IN B-PP O
reaction NN B-NP O
, , O O
such JJ B-PP O
as IN I-PP O
tomato NN B-NP O
based VBN B-VP O
sauces VBZ B-NP O
and CC O O
tries VBZ B-VP O
to TO I-VP O
avoid VB B-VP O
them PRP B-NP O
as RB B-ADVP O
much RB I-ADVP O
as IN B-PP O
possible JJ B-ADJP O
. . O O
The DT B-NP O
patient NN I-NP O
is VBZ B-VP O
asking VBG I-VP O
me PRP B-NP O
about IN B-PP O
Prilosec NNP B-NP O
which WDT B-NP O
he PRP B-NP O
recently RB B-ADVP O
read VBD B-VP O
in IN B-PP O
the DT B-NP O
Journal NNP I-NP O
and CC O O
was VBD B-VP O
wandering VBG I-VP O
whether IN B-PP O
this DT O O
would MD B-VP O
be VB I-VP O
a DT B-NP O
suitable JJ I-NP O
alternative NN I-NP O
to TO B-PP O
H2 CD B-NP O
blockers NNS I-NP O
( -LRB- O O
Patient NNP B-NP O
had VBD B-VP O
been VBN I-VP O
on IN B-PP O
H2 CD B-NP O
blockers NNS B-NP O
for IN B-PP O
many JJ B-NP O
years NNS I-NP O
without IN B-PP O
a DT B-NP O
trial NN I-NP O
off IN B-PP O
of IN B-PP O
them PRP B-NP O
, , O O
which WDT B-NP O
a DT B-NP O
reason NN I-NP O
that WDT O O
we PRP B-NP O
stopped VBD B-VP O
his PRP$ B-NP O
H2 NNP I-NP O
blocker NN I-NP O
therapy NN I-NP O
recently RB B-ADVP O
) -RRB- B-VP O
. . O O
With IN B-SBAR O
regard NN B-NP O
to TO B-PP O
the DT B-NP O
patient NN I-NP O
's POS B-NP O
symptoms NNS I-NP O
of IN B-PP O
benign JJ B-NP O
prostatic JJ I-NP O
hypertrophy NN I-NP O
, , O O
the DT B-NP O
patient NN I-NP O
says VBZ B-VP O
that IN B-SBAR O
these DT B-NP O
have VBP B-VP O
almost RB I-VP O
completely RB I-VP O
resolved VBN I-VP O
on IN B-PP O
the DT B-NP O
4 CD I-NP O
mg NN I-NP O
of IN B-PP O
Hytrin NNP B-NP O
and CC O O
which WDT B-NP O
he PRP B-NP O
will MD B-VP O
continue VB I-VP O
taking VBG I-VP O
. . B-NP O
The DT B-NP O
patient NN I-NP O
does VBZ B-VP O
remain VB I-VP O
on IN B-PP O
Zestril NNP B-NP O
for IN B-PP O
his PRP$ B-NP O
hypertension NN I-NP O
as RB B-CONJP O
well RB I-CONJP O
as IN I-CONJP O
the DT B-NP O
Hytrin NNP I-NP O
and CC O O
the DT B-NP O
blood NN I-NP O
pressure NN B-NP O
gotten VBN B-VP O
by IN B-PP O
the DT B-NP O
nurse NN I-NP O
today NN I-NP O
was VBD B-VP O
150/8 CD B-NP O
0 CD I-NP O
and CC O O
repeated VBN B-VP O
by IN B-PP O
me PRP B-NP O
20 CD O O
minutes NNS B-NP O
later RB B-ADVP O
was VBD B-VP O
130/74 CD B-NP O
. . O O
The DT B-NP O
patient JJ I-NP O
reports NNS I-NP O
being VBG B-VP O
otherwise RB B-ADVP O
well RB I-ADVP O
, , O O
no DT B-NP O
new JJ I-NP O
symptoms NNS I-NP O
. . O O
No DT O O
positive JJ O O
review NN B-NP O
of IN B-PP O
systems NNS B-NP O
. . O O
PHYSICAL NNP B-NP O
EXAM NNP I-NP O
: : O O
Was VBD B-VP O
not RB I-VP O
performed VBN I-VP O
. . B-NP O
Vitals NNP I-NP O
: : O O
Blood NN B-NP O
pressure NN I-NP O
taken VBN B-VP O
by IN B-PP O
me PRP B-NP O
was VBD B-VP O
130/74 CD B-NP O
in IN B-PP O
the DT B-NP O
right NN I-NP O
, , O O
130/74 CD B-NP O
in IN B-PP O
the DT B-NP O
left JJ I-NP O
, , I-NP O
temperature NN I-NP O
was VBD B-VP O
98.8 CD B-NP O
, , O O
respirations NNS B-NP O
20 CD B-NP O
, , O O
unlabored JJ B-NP O
and CC I-NP O
pulse NN I-NP O
was VBD B-VP O
80 CD B-NP O
. . O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
: : O O
75 CD B-NP B-AGE
year NN I-NP O
old JJ I-NP O
man NN I-NP O
with IN B-PP O
multiple JJ B-NP O
medical JJ I-NP O
concerns NNS I-NP O
comes VBZ B-VP O
in IN B-PP O
for IN B-NP O
follow VB B-VP O
up RB B-PRT O
. . O O
1 LS O O
. . B-NP O
Hypertension NNP I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
will MD B-VP O
stay VB I-VP O
on IN B-PP O
his PRP$ B-NP O
Zestril NNP I-NP O
, , O O
once RB B-ADVP O
a DT B-NP O
day NN I-NP O
as IN B-SBAR O
well RB B-ADVP O
as IN B-PP O
his PRP$ B-NP O
Hytrin NNP I-NP O
, , O O
which WDT B-NP O
he PRP B-NP O
uses VBZ B-VP O
also RB B-ADVP O
for IN B-PP O
BPH. NNP B-NP O
His PRP$ B-NP O
blood NN I-NP O
pressure NN I-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
well RB I-VP O
controlled VBN I-VP O
on IN B-PP O
this DT B-NP O
regimen LS I-NP O
. . O O
One CD B-NP O
of IN B-PP O
the DT B-NP O
issues NNS I-NP O
would MD B-VP O
be VB I-VP O
whether IN B-PP O
or CC O O
not RB O O
the DT B-NP O
patient NN I-NP O
should MD B-VP O
be VB I-VP O
on IN B-PP O
a DT B-NP O
beta-blocker NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
verbally RB B-ADVP O
has VBZ B-VP O
a DT B-NP O
history NN I-NP O
of IN B-PP O
" `` O O
a DT B-NP O
silent JJ I-NP O
heart NN I-NP O
attack NN I-NP O
" '' O O
and CC O O
there EX B-NP O
is VBZ B-VP O
evidence NN B-NP O
of IN B-PP O
an DT B-NP O
inferior JJ I-NP O
wall NN I-NP O
MI NNP I-NP O
and CC O O
this DT B-NP O
is VBZ B-VP O
certainly RB B-ADVP O
an DT B-NP O
option NN B-NP O
we PRP B-NP O
will MD B-VP O
consider VB I-VP O
in IN B-PP O
the DT B-NP O
future NN I-NP O
, , O O
although IN B-SBAR O
I PRP B-NP O
would MD B-VP O
not RB I-VP O
add VB I-VP O
a DT O O
third JJ B-NP O
anti-hypertensive JJ I-NP O
regimen NNS I-NP O
and CC O O
would MD B-VP O
most RBS I-VP O
likely JJ I-VP O
replace VB I-VP O
his PRP$ B-NP O
Zestril NNP B-NP O
with IN B-PP O
a DT B-NP O
beta-blocker NN I-NP O
. . O O
2. . B-NP O
GERD. NNP I-NP O
The DT O O
patient NN B-NP O
will MD B-VP O
be VB I-VP O
given VBN I-VP O
a DT B-NP O
prescription NN I-NP O
for IN B-PP O
Prilosec NNP B-NP O
20 CD I-NP O
mg NN I-NP O
to TO B-VP O
be VB I-VP O
taken VBN I-VP O
at IN B-PP O
bedtime NN B-NP O
. . O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
told VBN I-VP O
that IN B-SBAR O
this DT B-NP O
would MD B-VP O
not RB O O
MARTHA NNP B-NP B-HOSPITAL
JEFFERSON NNP I-NP I-HOSPITAL
HOSPITAL NNP I-NP I-HOSPITAL
Stephen NNP B-NP B-DOCTOR
A.N. NNP I-NP I-DOCTOR
Xayachack NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
004 CD B-NP B-STREET
Will MD O I-STREET
St NNP B-NP I-STREET
Vicente NNP I-NP I-PATIENT
, , O I-PATIENT
Kadeem NNP B-NP I-PATIENT
Sandpoint NNP B-NP B-CITY
, , O O
MI NNP B-NP B-STATE
58543 CD I-NP B-ZIP
CK759182 . O B-MEDICALRECORD
( -LRB- B-NP I-PHONE
033 CD I-NP I-PHONE
) -RRB- I-NP I-PHONE
250-1408 CD I-NP I-PHONE
3-6-93 CD O B-DATE
Page NNP B-NP O
2 CD I-NP O
be VB B-VP O
long JJ B-NP O
term NN I-NP O
therapy NN I-NP O
but CC O O
that IN B-SBAR O
we PRP B-NP O
can MD B-VP O
do VB I-VP O
this DT B-NP O
for IN B-PP O
the DT B-NP O
next JJ I-NP O
2-3 CD I-NP O
months NNS B-NP O
, , O O
although IN B-SBAR O
he PRP B-NP O
should MD B-VP O
be VB I-VP O
able JJ B-ADJP O
to TO B-VP O
experience VB I-VP O
relief NN B-NP O
almost RB O O
immediately RB B-ADVP O
. . O O
The DT B-NP O
patient NN I-NP O
does VBZ B-VP O
have VB I-VP O
a DT B-NP O
known VBN I-NP O
hiatal NN I-NP O
hernia NN I-NP O
, , O O
which WDT O O
may MD B-NP O
also RB B-ADVP O
contribute VB B-VP O
to TO B-PP O
his PRP$ B-NP O
symptoms NNS I-NP O
of IN B-PP O
chronic NN B-NP O
reflux NN I-NP O
. . O O
3. CD B-NP O
BPH NNP I-NP O
- : O O
The DT B-NP O
patient NN I-NP O
will MD B-VP O
stay VB I-VP O
on IN B-PP O
his PRP$ B-NP O
4 CD I-NP O
mg NN I-NP O
of IN B-PP O
Hytrin NNP B-NP O
, , O O
which WDT B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB B-VP O
working VBG I-VP O
quite RB B-ADVP O
well RB I-ADVP O
. . O O
The DT B-NP O
patient NN I-NP O
notes VBZ B-VP O
that IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
less RBR B-ADVP O
dribbling VBG B-VP O
, , O O
less JJR B-NP O
nocturnal JJ I-NP O
urination NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
does VBZ B-VP O
take VB I-VP O
Lasix NNP B-NP O
20 CD B-NP O
mg NN I-NP O
once IN B-PP O
a DT B-NP O
day NN I-NP O
for IN B-PP O
congestive JJ B-NP O
heart NN I-NP O
failure NN I-NP O
and CC O O
did VBD B-VP O
not RB I-VP O
have VB I-VP O
any DT O O
difficulty NN B-NP O
with IN B-PP O
urination NN B-NP O
after IN B-SBAR O
he PRP B-NP O
takes VBZ B-VP O
the DT B-NP O
diuretic JJ I-NP O
. . O O
4 LS O O
. . B-NP O
Insomnia NNP I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
will MD B-VP O
stay VB I-VP O
on IN B-PP O
his PRP$ B-NP O
Ambien JJ I-NP O
10 CD I-NP O
mg NN I-NP O
which WDT B-NP O
he PRP B-NP O
takes VBZ B-VP O
on IN B-PP O
a DT B-NP O
q.h JJ I-NP O
.s NNS I-NP O
. . B-NP O
basis NN I-NP O
. . O O
The DT B-NP O
patient NN I-NP O
was VBD B-VP O
formerly RB B-ADVP O
on IN B-PP O
Amitriptyline NNP B-NP O
but CC O O
was VBD B-VP O
told VBN I-VP O
that IN B-PP O
the DT B-NP O
secondary JJ I-NP O
side NN I-NP O
effects NNS I-NP O
which WDT B-NP O
can MD B-VP O
include VB I-VP O
EKG NNS B-NP O
changes NNS B-NP O
and CC B-PP O
at IN B-PP O
this DT B-NP O
point NN I-NP O
tells VBZ B-VP O
me PRP B-NP O
that IN B-SBAR O
the DT B-NP O
Ambien JJ I-NP O
works NNS I-NP O
and CC O O
he PRP B-NP O
would MD B-VP O
like VB I-VP O
to TO I-VP O
stay VB I-VP O
on IN B-PP O
this DT B-NP O
. . O O
Patient NNP O O
has VBZ B-VP O
enough RB I-VP O
to TO I-VP O
last VB I-VP O
until IN B-SBAR O
I PRP B-NP O
see VBP O O
him PRP B-NP O
next JJ B-NP O
time NN I-NP O
. . O O
I PRP B-NP O
will MD B-VP O
thus RB I-VP O
see VB I-VP O
the DT B-NP O
patient NN I-NP O
in IN B-PP O
3 CD B-NP O
months NNS I-NP O
for IN B-PP O
a DT B-NP O
fasting JJ I-NP O
lipid NN I-NP O
( -LRB- O O
The DT O O
patient NN B-NP O
's POS B-NP O
lipid JJ I-NP O
profile NN I-NP O
thus RB B-ADVP O
far RB B-ADVP O
has VBZ B-VP O
been VBN I-VP O
acceptable JJ B-ADJP O
. . O O
The DT B-NP O
cholesterol NN I-NP O
is VBZ B-VP O
190 CD B-NP O
and CC O O
an DT B-NP O
acceptable JJ I-NP O
triglyceride NN I-NP O
; : O O
however RB B-ADVP O
, , O O
I PRP B-NP O
do VBP B-VP O
want VB I-VP O
to TO I-VP O
assess VB I-VP O
the DT O O
patient NN B-NP O
's POS B-NP O
LDL NNP I-NP O
and CC I-NP O
HDL NNP I-NP O
before IN B-PP O
making VBG B-VP O
any DT B-NP O
decisions NNS I-NP O
with IN B-PP O
regard NN B-NP O
to TO B-LST O
treatment NN B-NP O
. . O O
Stephen NNP B-NP B-DOCTOR
A.N. NNP I-NP I-DOCTOR
Xayachack NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
JG:WQ:6672 . O B-IDNUM
DD NNP B-NP O
: : O O
3-7-93 CD O B-DATE
DT NNP B-NP O
: : O O
3-7-93 CD O B-DATE
DV NNP B-NP O
: : O O
3-6-93 CD O B-DATE
******** NN B-NP O
Not RB B-VP O
reviewed VBN I-VP O
by IN B-PP O
Attending VBG B-VP O
Physician JJ B-NP O
******** NNS I-NP O
